Title : The evolving role of testosterone in the treatment of erectile dysfunction.

Pub. Date : 2006 Sep

PMID : 16939550






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A number of laboratory and human studies have shown the combination of testosterone and other ED treatments, such as phosphodiesterase type 5 (PDE5) inhibitors, to be beneficial in patients with ED and hypogonadism, who fail PDE5 inhibitor therapy alone. Testosterone phosphodiesterase 5A Homo sapiens
2 A number of laboratory and human studies have shown the combination of testosterone and other ED treatments, such as phosphodiesterase type 5 (PDE5) inhibitors, to be beneficial in patients with ED and hypogonadism, who fail PDE5 inhibitor therapy alone. Testosterone phosphodiesterase 5A Homo sapiens
3 A number of laboratory and human studies have shown the combination of testosterone and other ED treatments, such as phosphodiesterase type 5 (PDE5) inhibitors, to be beneficial in patients with ED and hypogonadism, who fail PDE5 inhibitor therapy alone. Testosterone phosphodiesterase 5A Homo sapiens
4 Testosterone replacement therapy has potentially evolved from a monotherapy for ED in cases of low testosterone, to a combination therapy with PDE5 inhibitors. Testosterone phosphodiesterase 5A Homo sapiens